Analysts Offer Insights on Healthcare Companies: Radnet (RDNT) and Crispr Therapeutics AG (CRSP)
TipRanks (Thu, 15-Jan 8:20 AM ET)
RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026
Globe Newswire (Fri, 9-Jan 6:00 AM ET)
RadNet Expands to Southwest Florida with Acquisition of Radiology Regional
Globe Newswire (Wed, 7-Jan 6:15 AM ET)
RadNet Names Four Leaders to Expanded Executive Roles
Globe Newswire (Wed, 7-Jan 6:00 AM ET)
The Oncology Institute Announces Addition of Board Member Mark Stolper
Globe Newswire (Mon, 5-Jan 8:30 AM ET)
Globe Newswire (Mon, 1-Dec 6:00 AM ET)
Globe Newswire (Sun, 30-Nov 8:00 AM ET)
RadNet's DeepHealth Announces Wichita Radiological Group as First Operations Suite Customer
Globe Newswire (Thu, 20-Nov 6:00 AM ET)
Globe Newswire (Mon, 17-Nov 4:05 PM ET)
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Radnet trades on the NASDAQ stock market under the symbol RDNT.
As of January 16, 2026, RDNT stock price declined to $72.12 with 30,484 million shares trading.
RDNT has a beta of 1.07, meaning it tends to be more sensitive to market movements. RDNT has a correlation of 0.14 to the broad based SPY ETF.
RDNT has a market cap of $5.57 billion. This is considered a Mid Cap stock.
Last quarter Radnet reported $523 million in Revenue and $.20 earnings per share. This beat revenue expectation by $27 million and missed earnings estimates by -$.03.
In the last 3 years, RDNT traded as high as $93.65 and as low as $19.79.
The top ETF exchange traded funds that RDNT belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
RDNT has underperformed the market in the last year with a price return of +16.8% while the SPY ETF gained +18.2%. RDNT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.1% and +1.1%, respectively, while the SPY returned +4.6% and +1.7%, respectively.
RDNT support price is $70.89 and resistance is $75.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDNT shares will trade within this expected range on the day.